Compare
Merit Medical Systems vs West Pharmaceutical Services (MMSI vs WST)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Merit Medical Systems (MMSI) returned +0.1% and West Pharmaceutical Services (WST) +41.0%; so far this year the figures are -1.0% and +45.3%.
West Pharmaceutical Services is the larger company by market value, about 5.3 times the size of Merit Medical Systems.
On trailing earnings, MMSI trades at 32.7 times and WST at 44.9 times.
Revenue grew +9.1% at MMSI and +12.6% at WST over the last year.
MMSI pays no dividend. WST yields 0.22%.
Data as of the latest close. Not investment advice.
Relative performance
| MMSI | WST | |
|---|---|---|
| Price | $87.23 | $399.81 |
| 1-day | -2.67% | +1.87% |
| YTD | -1.03% | +45.31% |
| 1 year | +0.14% | +41.01% |
| 3 years | +22.76% | +24.29% |
| Market cap | $5.2B | $27.9B |
| P/E | 32.7 | 44.9 |
| P/S | 3.24 | 8.20 |
| P/B | 3.00 | 9.38 |
| Revenue growth | +9.10% | +12.60% |
| EPS growth | +36.90% | +32.00% |
| Gross margin % | 49.4 | 37.6 |
| Net margin % | 9.9 | 18.8 |
| ROE % | 9.2 | 21.5 |
| Debt / equity | 0.42 | 0.07 |
| FCF yield % | 3.9 | 1.6 |
| Dividend yield % | — | 0.22 |
| Beta | 0.51 | 0.66 |
| RSI (14) | 46.3 | 57.5 |
| Technical rating |